Resultats de la cerca - Tyagi, Sandeep

Refinar resultats
  1. 1
    Designer Arrays for Defined Mutant Analysis To Detect Genes Essential for Survival of Mycobacterium tuberculosis in Mouse Lungs

    Designer Arrays for Defined Mutant Analysis To Detect Genes Essential for Survival of Mycobacterium tuberculosis in Mouse Lungs per Lamichhane, Gyanu, Tyagi, Sandeep, Bishai, William R.

    Publicat 2005
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  2. 2
    Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model

    Verapamil Increases the Bactericidal Activity of Bedaquiline against Mycobacterium tuberculosis in a Mouse Model per Gupta, Shashank, Tyagi, Sandeep, Bishai, William R.

    Publicat 2014
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  3. 3
    Characterization of the Mycobacterium tuberculosis Sigma Factor SigM by Assessment of Virulence and Identification of SigM-Dependent Genes

    Characterization of the Mycobacterium tuberculosis Sigma Factor SigM by Assessment of Virulence and Identification of SigM-Dependent Genes per Agarwal, Nisheeth, Woolwine, Samuel C., Tyagi, Sandeep, Bishai, William R.

    Publicat 2007
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  4. 4
    Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis

    Enhanced Bactericidal Activity of Rifampin and/or Pyrazinamide When Combined with PA-824 in a Murine Model of Tuberculosis per Tasneen, Rokeya, Tyagi, Sandeep, Williams, Kathy, Grosset, Jacques, Nuermberger, Eric

    Publicat 2008
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  5. 5
    In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis

    In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis per Almeida, Deepak, Nuermberger, Eric, Tyagi, Sandeep, Bishai, William R., Grosset, Jacques

    Publicat 2007
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  6. 6
    The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases

    The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases per Tyagi, Sandeep, Gupta, Paras, Saini, Arminder Singh, Kaushal, Chaitnya, Sharma, Saurabh

    Publicat 2011
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  7. 7
    Bactericidal Activity of Increasing Daily and Weekly Doses of Moxifloxacin in Murine Tuberculosis

    Bactericidal Activity of Increasing Daily and Weekly Doses of Moxifloxacin in Murine Tuberculosis per Yoshimatsu, Tetsuyuki, Nuermberger, Eric, Tyagi, Sandeep, Chaisson, Richard, Bishai, William, Grosset, Jacques

    Publicat 2002
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  8. 8
    Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay

    Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay per Converse, Paul J., Almeida, Deepak V., Tyagi, Sandeep, Xu, Jian, Nuermberger, Eric L.

    Publicat 2019
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  9. 9
    Use of blood components in critically ill patients in the medical intensive care unit of a tertiary care hospital

    Use of blood components in critically ill patients in the medical intensive care unit of a tertiary care hospital per Makroo, R N, Mani, R. K., Vimarsh, Raina, Kansal, Sudha, Pushkar, Kumar, Tyagi, Sandeep

    Publicat 2009
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  10. 10
    Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis

    Bactericidal Activity of the Nitroimidazopyran PA-824 in a Murine Model of Tuberculosis per Tyagi, Sandeep, Nuermberger, E., Yoshimatsu, T., Williams, K., Rosenthal, I., Lounis, N., Bishai, W., Grosset, J.

    Publicat 2005
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  11. 11
    Rifapentine, Moxifloxacin, or DNA Vaccine Improves Treatment of Latent Tuberculosis in a Mouse Model

    Rifapentine, Moxifloxacin, or DNA Vaccine Improves Treatment of Latent Tuberculosis in a Mouse Model per Nuermberger, Eric, Tyagi, Sandeep, Williams, Kathy N., Rosenthal, Ian, Bishai, William R., Grosset, Jacques H.

    Publicat 2005
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  12. 12
    Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens with or without Continuation of Pyrazinamide in Murine Tuberculosis

    Contribution of Moxifloxacin or Levofloxacin in Second-Line Regimens with or without Continuation of Pyrazinamide in Murine Tuberculosis per Ahmad, Zahoor, Tyagi, Sandeep, Minkowski, Austin, Peloquin, Charles A., Grosset, Jacques H., Nuermberger, Eric L.

    Publicat 2013
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  13. 13
    Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

    Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis per Nuermberger, Eric, Tyagi, Sandeep, Tasneen, Rokeya, Williams, Kathy N., Almeida, Deepak, Rosenthal, Ian, Grosset, Jacques H.

    Publicat 2008
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  14. 14
    Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis

    Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis per Almeida, Deepak, Nuermberger, Eric, Tasneen, Rokeya, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy, Peloquin, Charles, Grosset, Jacques

    Publicat 2009
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  15. 15
    Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy

    Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy per Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.

    Publicat 2013
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  16. 16
    Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor

    Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor per Gupta, Shashank, Tyagi, Sandeep, Almeida, Deepak V., Maiga, Mariama C., Ammerman, Nicole C., Bishai, William R.

    Publicat 2013
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  17. 17
    Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations

    Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations per Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.

    Publicat 2015
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  18. 18
    Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies

    Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies per Zhang, Nan, Strydom, Natasha, Tyagi, Sandeep, Soni, Heena, Tasneen, Rokeya, Nuermberger, Eric L., Savic, Rada M.

    Publicat 2020
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  19. 19
    Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease

    Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease per Almeida, Deepak V., Converse, Paul J., Li, Si-Yang, Tyagi, Sandeep, Nuermberger, Eric L., Grosset, Jacques H.

    Publicat 2013
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:
  20. 20
    Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

    Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis per Li, Si-Yang, Tasneen, Rokeya, Tyagi, Sandeep, Soni, Heena, Converse, Paul J., Mdluli, Khisimuzi, Nuermberger, Eric L.

    Publicat 2017
    Obtenir text complet Obtenir text complet Obtenir text complet
    Text
    Afegir a favorits
    Guardat en:

Eines de cerca: